Brachytherapy

Post-Brachytherapy Erectile Function Preserved in Most Men

Post-Brachytherapy Erectile Function Preserved in Most Men

By

At 5 years after seed implantation, 59% prostate cancer patients had preserved erectile function.

Post-Brachytherapy PSA Bounce Linked to Sexual Activity

Post-Brachytherapy PSA Bounce Linked to Sexual Activity

By

PSA bounce was associated with significantly higher scores on the International Index of Erectile Function-15 questionnaire.

Prostate Brachytherapy On the Decline

Prostate Brachytherapy On the Decline

By

Use of this treatment for localized prostate cancer has been decreasing since 2002, perhaps due to increasing use of radical prostatectomy.

Radiotherapy Combo Superior for Intermediate-Risk Prostate Cancer

Radiotherapy Combo Superior for Intermediate-Risk Prostate Cancer

By

IMRT plus brachytherapy offers better PSA relapse-free and metastasis-free survival than high-dose IMRT alone.

Radiation Combo for High-Risk Prostate Cancer Offers Good Outcomes

Radiation Combo for High-Risk Prostate Cancer Offers Good Outcomes

By

In a study, the five-year biochemical failure-free survival rate was nearly 85%.

New Approach Promising for Penile Cancer

By

Researchers report good results using high-dose rather than low-dose interstitial brachytherapy.

Brachytherapy a Good Option for Younger Prostate Cancer Patients

By

By itself or combined with external beam radiation therapy, it offers excellent oncologic outcomes.

Focal Therapy for Prostate Cancer Advances

Focal Therapy for Prostate Cancer Advances

By

Modalities under investigation include laser ablation, hemiablative seed implantation, and results are promising.

Hematuria May Occur Years After Brachytherapy

By

Men with larger prostates are at higher risk for blood in urine.

Perineural Invasion Predicts PSA Relapse After Brachytherapy

By

Perineural invasion (PNI) and post-treatment PSA levels at 12 months strongly predict long-term PSA relapse-free survival (PRFS) after definitive brachytherapy seed implantation for prostate cancer (PCa), according to a study.

Brachytherapy May Be Underused

By

Brachytherapy appears to have significant advantages over EBRT in the treatment of men with low-risk and intermediate-risk prostate cancer.

The Case for Brachytherapy: Interview with Michael Sarosdy, MD

The Case for Brachytherapy: Interview with Michael Sarosdy, MD

By

Having performed more than 1,200 brachytherapy treatments, Michael F. Sarosdy, MD, is convinced that this is a far better choice than surgery.

Data Support Cystoscopy Prior to Brachytherapy

By

PARIS—Cystoscopy prior to low dose rate (LDR) brachytherapy for prostate cancer is feasible and useful in identifying patients who require further investigation or intervention before seed implantation, researchers reported at the 27th Annual Congress of the European Association of Urology.

A New Radiotherapy Option for Prostate Cancer

By

Noninvasive brachytherapy-like treatment may be a new option for men with prostate cancer.

Brachytherapy May Be An Option for Men with High-Risk Prostate Cancer

By

SAN FRANCISCO—Brachytherapy may be a treatment option for patients with high-risk prostate cancer (HRPC), according to data presented here at the annual Genitourinary Cancers Symposium.

Triple-Regimen Benefits Men with Intermediate-Risk Prostate Cancer

By

Combined external beam radiation therapy (EBRT) with a brachytherapy boost plus androgen deprivation therapy (ADT) is associated with excellent disease-free survival among men with intermediate-risk prostate cancer (PCa), researchers reported.

Erectile Function Two Years After Prostate Cancer Treatment Predictable

By

Investigators at Harvard Medical School in Boston developed models for predicting effective for predicting erectile function two years after prostatectomy, external radiotherapy, or brachytherapy for prostate cancer. John Schieszer has the story in today's Medical Minute.

GI Toxicities After Radiotherapy for PCa Persist Beyond Five Years

By

The lowest rate of these complications was observed among patients treated with brachytherapy alone.

Brachytherapy Very Effective Long-Term

By

Brachytherapy offers excellent oncologic outcomes and is associated with a low rate of adverse events, data show.

Brachytherapy An Option for Younger Prostate Cancer Patients

By

Brachytherapy may provide an effective alternative treatment for younger men who are reluctant to undergo surgery for favorable risk prostate cancer, according to Canadian researchers.

Adding Hormone Therapy to Brachytherapy May Raise Death Risk in Older Men

By

Adding androgen deprivation therapy (ADT) to brachytherapy for localized prostate cancer may increase the risk of death among men aged 73 years and older, data suggest.

An Alternative to Radical Cystectomy

By

Bladder-sparing protocol involving brachytherapy and EBRT shows promise in bladder cancer patients.

High-Grade Prostate Cancer Treated with Triple Combo

By

A triple combination of brachytherapy, external beam radiotherapy (EBRT), and hormonal therapy is associated with favorable outcomes in men with high-grade prostate cancer and should be considered a viable treatment option in these patients, a study showed.

Caution Urged with Prebrachytherapy AST

By

ORLANDO—Neoadjuvant androgen suppression therapy (AST) prior to brachytherapy may be associated with an increased risk of all-cause mortality in men with favorable-risk prostate cancer who have pre-existing cardiovascular disease (CVD).

Urethral Strictures After HDR Brachytherapy Characterized

By

Bulbomembranous (BM) urethral strictures are the most common grade 2 or higher urinary toxicity following high dose rate brachytherapy (HDRB), according to Australian investigators.

Pre-Brachytherapy Hormones May Harm

By

BOSTON—Men older than 70 years who have localized prostate cancer may be at increased risk of death if they receive neoadjuvant hormone therapy (NHT) before being treated with brachytherapy compared with men treated with brachytherapy alone, data show.

Radiotherapy for Prostate Cancer Is on the Rise

By

BOSTON—Use of radiotherapy (RT) for prostate cancer has been increasing over the past three decades, according to researchers. Brachytherapy, either as part of treatment or as monotherapy, has paralleled this rise.

Brachytherapy Sexual Effects Defined

By

BERLIN—Two recent French studies have characterized the effect of prostate brachytherapy on erectile and ejaculatory function.

Early Use of ED Drugs Beneficial

By

Early use of phosphodiesterase inhibitors (PDEIs) following brachytherapy is associated with improved erectile function compared with late use of the drugs.

Study: Brachytherapy Alone Is Effective

By

Patients with intermediate-risk prostate cancer may be effectively treated with brachytherapy without supplemental pelvic radiotherapy, according to new findings.

Sign Up for Free e-newsletters